NCT04159675View on ClinicalTrials.gov

Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

April 4, 2026

Study Completion Date

April 4, 2026

Conditions
Craniosynostoses
Interventions
BIOLOGICAL

osteoblast biology study

Describe the in-vitro action of burosumab and vitamin D on human osteoblastogenesis from osteoblasts from patients with craniosynostosis due to HR

Trial Locations (1)

69500

RECRUITING

Centre de référence des craniosténoses et malformations cranio-faciales Service de neurochirurgie Pédiatrique, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER